Model Number DIMENSION VISTA 1500 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problem
No Known Impact Or Consequence To Patient (2692)
|
Event Date 04/28/2017 |
Event Type
malfunction
|
Manufacturer Narrative
|
The customer contacted a siemens customer care center and stated that they cleaned the drains and probes of aliquot reagent 1 probe, reagent 2 probe and sample 1 probe.The customer repeated the sample in question and the result was acceptable.The customer did not obtain additional discordant results.The cause of the discordant, falsely low bhcg result on one patient sample is unknown.The instrument is performing within manufacturing specifications.No further evaluation of device is required.
|
|
Event Description
|
A discordant, falsely low beta human chorionic gonadotropin (bhcg) result was obtained on one patient sample on a dimension vista 1500 instrument.The discordant result was not reported to the physician(s).The sample was repeated on the same instrument and on an alternate dimension vista instrument, resulting higher both times.The result obtained on the alternate dimension vista instrument was reported to the physician(s).There are no reports of patient intervention or adverse health consequence due to the discordant, falsely low bhcg result.
|
|
Manufacturer Narrative
|
The initial mdr 2517506-2017-00495 was filed on may 18, 2017.Additional information (07/19/2017): a siemens headquarters support center (hsc) specialist reviewed the information provided by the customer and determined that prior to and after the discordant result was obtained, quality control was run from the same well set and was within acceptable range.Sample for the repeat run was reintroduced on the system with a small sample container cup and was repeated on an alternate dimension vista instrument, which matched the expected result.There was no indication that the system was malfunctioning or having an issue with the beta human chorionic gonadotropin (bhcg) assay around this time.There was no mention of sample handling or pre-analytical factors.The hsc specialist stated the initial sample from the primary tube could potentially introduced fibrin or cellular debris, which may have caused the lower result.The hsc specialist recommended the customer to follow proper pre-analytical sample handling procedures and tube manufacturer's instructions, including mixing of the sample after phlebotomy to ensure complete dispersion of the anti-coagulant or clot activator throughout the sample in order to avoid latent fibrin formation in the serum or plasma portion of the sample.The cause of the discordant, falsely low bhcg result on one patient sample is unknown.
|
|
Search Alerts/Recalls
|